tradingkey.logo

DaVita rises on upbeat annual profit forecast

ReutersFeb 3, 2026 11:48 AM

Dialysis firm DaVita's DVA.N shares rise 10.6% to $121.05 premarket after co forecasts annual profit above estimates

Co expects 2026 adj. EPS to be between $13.60 and $15 vs analysts' average estimate of $12.65 - LSEG data

DVA attributes upbeat estimate to steady demand for its kidney dialysis services

Barclays raises PT to $158 from $143, an upside of 42% to DVA's last close of $111.19

Co expects headwind of $40 mln in 2026, $70 mln in 2027 with the expiration of the Affordable Care Act subsidy, but will be offset by elimination of $45 mln cyber-incident impact in 2025, says chief financial officer Joel Ackerman

Co reports Q4 adj. EPS of $3.4 vs analysts' estimate of $3.16 - LSEG data

Q4 profit lifted by higher reimbursement rates and a slight improvement in the mix and seasonal impact of flu vaccines, says co

DVA stock dropped 24% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI